74 related articles for article (PubMed ID: 2447438)
1. Effects of alpha 1-inhibition on lipid metabolism in the rat.
Woodside WF; Swindell AC
J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S27-34. PubMed ID: 2447438
[TBL] [Abstract][Full Text] [Related]
2. Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats.
Jansen H; Baggen RG
J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S16-20. PubMed ID: 2447435
[TBL] [Abstract][Full Text] [Related]
3. Chronic alpha 1-adrenergic blockade, serum triacylglycerols, and tissue lipoprotein lipase activity in rats fed diets high in starch or sucrose.
Deshaies Y; Martineau MJ; LaLonde J
Nutrition; 1991; 7(2):109-15; discussion 115-6. PubMed ID: 1686980
[TBL] [Abstract][Full Text] [Related]
4. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
Westheim A; Daae LN; Kierulf P; Brusletto B; Holme I; Syvertsen JO
J Hypertens Suppl; 1990 Sep; 8(5):S41-6. PubMed ID: 1981076
[TBL] [Abstract][Full Text] [Related]
5. Doxazosin: a new alpha 1-adrenergic antagonist.
Babamoto KS; Hirokawa WT
Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
[TBL] [Abstract][Full Text] [Related]
6. Metabolic changes during antihypertensive therapies.
Krone W; Nägele H
J Hum Hypertens; 1989 Dec; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
[TBL] [Abstract][Full Text] [Related]
7. Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model.
Foxall TL; Shwaery GT; Stucchi AF; Nicolosi RJ; Wong SS
Am J Pathol; 1992 Jun; 140(6):1357-63. PubMed ID: 1351367
[TBL] [Abstract][Full Text] [Related]
8. Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade.
Fliser D; Nowack R; Allendorf-Ostwald N; Kohl B; Hübinger A; Ritz E
Am J Hypertens; 1993 Apr; 6(4):320-4. PubMed ID: 8099492
[TBL] [Abstract][Full Text] [Related]
9. Influence of doxazosin on lipid transport in rats and hamsters.
Ontko JA; Woodside WF
J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S31-6; discussions 36-7. PubMed ID: 2471013
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term exercise and high-cholesterol diet on lipid-lipoprotein metabolism in rats.
Terao T; Fujise T; Nakano S
Tokai J Exp Clin Med; 1987 Nov; 12(4):243-51. PubMed ID: 3503394
[TBL] [Abstract][Full Text] [Related]
11. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
[TBL] [Abstract][Full Text] [Related]
12. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
[TBL] [Abstract][Full Text] [Related]
13. Cardio-protective role of terazosin is possibly mediated through alteration in thyroid function.
Jatwa R; Kar A
Eur J Pharmacol; 2006 Dec; 551(1-3):87-91. PubMed ID: 17027746
[TBL] [Abstract][Full Text] [Related]
14. Terazosin: a new antihypertensive agent with favorable effects on lipids.
Luther RR
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
[TBL] [Abstract][Full Text] [Related]
15. Meal frequency; does it determine postprandial lipaemia?
Murphy MC; Chapman C; Lovegrove JA; Isherwood SG; Morgan LM; Wright JW; Williams CM
Eur J Clin Nutr; 1996 Aug; 50(8):491-7. PubMed ID: 8863008
[TBL] [Abstract][Full Text] [Related]
16. Studies with doxazosin on the saturable binding of 125I-LDL by liver in normocholesterolemic mice.
Nanjee MN; Miller NE
J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S35-41. PubMed ID: 2447439
[TBL] [Abstract][Full Text] [Related]
17. Changes in serum lipoprotein lipids and their fatty acid compositions and lipid peroxidation in growing rats fed soybean protein versus casein with or without cholesterol.
Madani S; Frenoux JM; Prost J; Belleville J
Nutrition; 2004 Jun; 20(6):554-63. PubMed ID: 15165619
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate restriction and dietary cholesterol distinctly affect plasma lipids and lipoprotein subfractions in adult guinea pigs.
Torres-Gonzalez M; Leite JO; Volek JS; Contois JH; Fernandez ML
J Nutr Biochem; 2008 Dec; 19(12):856-63. PubMed ID: 18495466
[TBL] [Abstract][Full Text] [Related]
20. Prazosin lowers plasma triglyceride concentration in rats: a preliminary report.
Reaven GM; Dall'Aglio E
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S248-50. PubMed ID: 6177967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
